| Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma. | lymphoma, |
| ETO protein of t(8;21) AML is a corepressor for Bcl-6 B-cell lymphoma oncoprotein. | lymphoma, |
| Protein expression of B-cell lymphoma gene 6 (BCL-6) in invasive breast cancer is associated with cyclin D1 and hypoxia-inducible factor-1alpha (HIF-1alpha). | lymphoma,breast, |
| Molecular characterization of BCL6 breakpoints in primary diffuse large B-cell lymphomas of the central nervous system identifies GAPD as novel translocation partner. | lymphoma, |
| Possible interaction between activator protein-1 and proto-oncogene B-cell lymphoma gene 6 in breast cancer patients resistant to tamoxifen. | lymphoma,breast, |
| Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells. | lymphoma, |
| Results define the oncogenic role of BCL6 in the pathogenesis of diffuse large B cell lymphomas (DLBCL) and provide a faithful mouse model of this common disease. | lymphoma, |
| The BCL6 proto-oncogene: a leading role during germinal center development and lymphomagenesis. | lymphoma, |
| BCL-6 oncoprotein in breast cancer: loss of expression in disease progression. | breast, |
| Identification and characterizaion of a specific, small-molecule inhibitor of BCL6, an oncogenic transcriptional repressor, that has high clinical promise for treating diffuse large B cell lymphoma. | lymphoma, |
| BCL6: master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis. | lymphoma, |
| DNA methylation prevents CTCF-mediated silencing of the oncogene BCL6 in B cell lymphomas. | lymphoma, |
| POZ-, AT-hook-, and zinc finger-containing protein (PATZ) interacts with human oncogene B cell lymphoma 6 (BCL6) and is required for its negative autoregulation. | lymphoma, |
| MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma. | lymphoma, |
| MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma. | lymphoma, |
| Altered B-cell lymphoma 6, a key oncogene in B-cell lymphomagenesis, may be involved in the pathogenesis of preeclampsia | lymphoma, |
| Targeted gene analysis: increased B-cell lymphoma 6 in preeclamptic placentas. | lymphoma, |
| Transient expression of Bcl6 is sufficient for oncogenic function and induction of mature B-cell lymphoma. | lymphoma, |
| The current study demonstrated the oncogenic property of BCL6 in breast cancer and further study could target BCL6 as a novel potential therapeutic strategy for breast cancer. | breast, |
| Translocation of the proto-oncogene Bcl-6 in human glioblastoma multiforme. | glioblastoma, |